Prof. Brown is a pioneer in Transcranial Magnetic Stimulation (TMS) and serves as current President of the Clinical TMS ...
The Horizon® 3.0 Inspire has a compact design allowing for easier portability. The Food and Drug Administration (FDA) has cleared Magstim’s Horizon ® 3.0 Inspire for the treatment of major depressive ...
News Medical on MSN
Five sessions a day TMS approach may reduce depression symptoms in one week
For the many patients with depression who haven't found relief through medication, transcranial magnetic stimulation (TMS) - ...
Magstim Passes Compliance with Strict European Union Medical Device Regulations Expanding Magstim Access to Entire EU Marketplace WHITLAND, United Kingdom, May 16, 2025 (GLOBE NEWSWIRE) -- Magstim has ...
MINNEAPOLIS and CARMARTHENSHIRE, United Kingdom, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Magstim, the global leader in neuroscience research and treatment for mental health, has been awarded FDA clearance ...
Magstim Inc. received U.S. FDA clearance for use of its Horizon 3.0 and E-z Cool Coil to treat adult patients diagnosed with both obsessive compulsive disorder (OCD) and major depressive disorder (MDD ...
QuantalX combined transcranial magnetic stimulation and EEG technology in its first-of-its-kind brain network function ...
A newly released educational resource provides a detailed, research-informed examination of “ TMS and ...
Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results